Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | MIF | P14174 | 1/20 | 0.31 |
| ▸ | SQLE | Q14534 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19411337 | 1.00 | LMNA (0.40) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL19411336 | 1.00 | LMNA (0.40) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL11144733 | 1.00 | LMNA (0.40) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL272453 | 1.00 | — | — | |
| SCHEMBL8973807 | 1.00 | LMNA (0.40) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL6606689 | 1.00 | — | — | |
| SCHEMBL4133064 | 0.97 | — | — | |
| SCHEMBL274098 | 0.86 | — | — | |
| SCHEMBL2904875 | 0.86 | — | — | |
| SCHEMBL11567726 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10342229-B2 | Aqueous coating compositions | SYNGENTA PARTICIPATIONS AG (CH) | 2019-07-09 | — | — | US | disclosed |
| EP-1833297-B1 | AQUEOUS COATING COMPOSITIONS | SYNGENTA LTD (GB) | 2017-08-30 | — | — | EP | disclosed |
| US-9259598-B2 | Aqueous dispersions of crystalline polymers and uses | Landec, Inc. (US) | 2016-02-16 | — | — | US | disclosed |
| US-20120308631-A1 | AQUEOUS COATING COMPOSITIONS | SYNGENTA CROP PROTECTION LLC (US) | 2012-12-06 | — | — | US | disclosed |
| US-20090208546-A1 | AQUEOUS COATING COMPOSITIONS | SYNGENTA CROP PROTECTION, INC. (US) | 2009-08-20 | — | — | US | disclosed |
| EP-1833297-A1 | AQUEOUS COATING COMPOSITIONS | Syngenta Limited (GB) | 2007-09-19 | — | — | EP | disclosed |
| US-20070104745-A1 | Aqueous dispersions of crystalline polymers and uses | STEWART RAY F | 2007-05-10 | — | — | US | disclosed |
| US-7175832-B2 | Aqueous dispersions of crystalline polymers and uses | LANDEC CORPORATION (US) | 2007-02-13 | — | — | US | disclosed |
| WO-2006070183-A1 | AQUEOUS COATING COMPOSITIONS | SYNGENTA LIMITED (GB) | 2006-07-06 | — | — | WO | disclosed |
| EP-1238714-B1 | Aqueous dispersions of crystalline polymers and their use | LANDEC CORP (US) | 2005-03-02 | — | — | EP | disclosed |
| US-20030147946-A1 | Aqueous dispersions of crystalline polymers and uses | LANDEC CORPORATION | 2003-08-07 | — | — | US | disclosed |
| EP-0949975-B1 | AQUEOUS DISPERSIONS OF CRYSTALLINE POLYMERS AND USES | LANDEC CORP (US) | 2002-10-02 | — | — | EP | disclosed |
| EP-1238714-A1 | Aqueous dispersions of crystalline polymers and uses | LANDEC CORPORATION (US) | 2002-09-11 | — | — | EP | disclosed |
| US-6199318-B1 | Aqueous emulsions of crystalline polymers for coating seeds | LANDEC CORPORATION | 2001-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10342229-B2 | Aqueous coating compositions | ACHE, CFL1, PWWP2B | LMNA 3599/4885ALDH1A1 2859/4885TSHR 4346/4885 |
| US-20120308631-A1 | AQUEOUS COATING COMPOSITIONS | ACHE, CFL1, PWWP2B | LMNA 3599/4885ALDH1A1 2859/4885TSHR 4346/4885 |
| US-20090208546-A1 | AQUEOUS COATING COMPOSITIONS | ACHE, CFL1, PWWP2B | LMNA 3599/4885ALDH1A1 2859/4885TSHR 4346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.